Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Hacettepe University Center for Genomics and Rare Diseases, Ankara, Turkey.
J Investig Med. 2024 Oct;72(7):684-696. doi: 10.1177/10815589241258964. Epub 2024 Jul 30.
, a notable drug-resistant bacterium, often induces severe infections in healthcare settings, prompting a deeper exploration of treatment alternatives due to escalating carbapenem resistance. This study meticulously examined clinical, microbiological, and molecular aspects related to in-hospital mortality in patients with carbapenem-resistant . (CRAB) bloodstream infections (BSIs). From 292 isolates, 153 cases were scrutinized, reidentified through matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), and evaluated for antimicrobial susceptibility and carbapenemase genes via multiplex polymerase chain reaction (PCR). Utilizing supervised machine learning, the study constructed models to predict 14- and 30-day mortality rates, revealing the Naïve Bayes model's superior specificity (0.75) and area under the curve (0.822) for 14-day mortality, and the Random Forest model's impressive recall (0.85) for 30-day mortality. These models delineated eight and nine significant features for 14- and 30-day mortality predictions, respectively, with "septic shock" as a pivotal variable. Additional variables such as neutropenia with neutropenic days prior to sepsis, mechanical ventilator support, chronic kidney disease, and heart failure were also identified as ranking features. However, empirical antibiotic therapy appropriateness and specific microbiological data had minimal predictive efficacy. This research offers foundational data for assessing mortality risks associated with CRAB BSI and underscores the importance of stringent infection control practices in the wake of the scarcity of new effective antibiotics against resistant strains. The advanced models and insights generated in this study serve as significant resources for managing the repercussions of . infections, contributing substantially to the clinical understanding and management of such infections in healthcare environments.
耐碳青霉烯肠杆菌(Carbapenem-Resistant )是一种重要的耐药菌,常导致医疗机构内严重感染,由于碳青霉烯类耐药性不断上升,迫切需要探索替代治疗方法。本研究细致探讨了耐碳青霉烯肠杆菌血流感染(Carbapenem-Resistant )患者住院期间死亡率的临床、微生物学和分子方面。从 292 株分离株中,对 153 例进行了重新鉴定,采用基质辅助激光解吸电离飞行时间质谱(Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry,MALDI-TOF-MS),并通过多重聚合酶链反应(Multiplex Polymerase Chain Reaction,PCR)检测抗菌药物敏感性和碳青霉烯酶基因。利用监督机器学习,构建模型预测 14 天和 30 天死亡率,发现朴素贝叶斯模型(Naive Bayes)对 14 天死亡率的特异性(0.75)和曲线下面积(Area Under the Curve,AUC)(0.822)较高,随机森林模型(Random Forest)对 30 天死亡率的召回率(Recall)较高(0.85)。这些模型分别为 14 天和 30 天死亡率预测确定了 8 个和 9 个重要特征,“感染性休克”是关键变量。其他变量如感染前中性粒细胞减少症和中性粒细胞减少天数、机械通气支持、慢性肾脏病和心力衰竭也被确定为重要特征。然而,经验性抗生素治疗的适当性和特定的微生物学数据对预测效果不大。本研究为评估耐碳青霉烯肠杆菌血流感染的死亡率风险提供了基础数据,并强调在新的有效抗生素对抗耐药菌株稀缺的情况下,严格感染控制措施的重要性。本研究中生成的先进模型和见解为管理耐碳青霉烯肠杆菌感染的后果提供了重要资源,对医疗机构中此类感染的临床理解和管理做出了重要贡献。